Australia's most trusted
source of pharma news
Posted 18 February 2025 AM
Novartis has entered into a Memorandum of Understanding (MoU) with the Hunter Medical Research Institute (HMRI), supported by the University of Newcastle to explore high impact innovative research - starting with lipid management and cardiovascular health.
The MoU is designed to support a long-term research partnership leveraging HMRI and University of Newcastle expertise in world-class research and Novartis’ leadership in pioneering medical solutions with the parties exploring opportunities to develop projects that align with their shared vision of advancing medical science and improving patient care.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.